37 Pulmonary Embolism Clinical Trials in Baltimore, MD (2026)

Q: How do I join a clinical trial in Baltimore?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you.

Recruiting Pulmonary Embolism Studies in Baltimore

NCT06525259Recruiting

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic ...

Baltimore, MD3,600 participantsGeorge Washington University

View Study Details

NCT03141021Recruiting

Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

First, the investigators plan to use a retrospective analysis to determine the clinical landscape of neurofibromatosis (NF)1-associated malignant peripheral nerve sheath tumor (MPNST) and precursor le...

Baltimore, MD1,050 participantsWashington University School of Medicine

View Study Details

NCT04633655Recruiting

International CIPN Assessment and Validation Study

This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an in...

Baltimore, MD1,000 participantsUniversity of Milano Bicocca

View Study Details

NCT06989775Recruiting

BoxX-NoAF Clinical Trial

Post Operative Atrial Fibrillation (POAF) is the most common complication of cardiac surgery. POAF incidence can exceed 50% depending on the patient baseline characteristics and surgery type. Patients...

Baltimore, MDNA960 participantsAtriCure, Inc.

View Study Details

NCT06986590Recruiting

Addressing Hypertension Care in Africa Program

The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors....

Baltimore, MDNA800 participantsJohns Hopkins University

View Study Details

NCT06102330Recruiting

Multicenter HomeVENT: Home Values and Experiences Navigation Track

This is a multicenter study to test a decision-making support process for families and clinicians facing decisions about chronic home ventilation for a child. The investigators hypothesize that the in...

Baltimore, MDNA600 participantsJohns Hopkins University

View Study Details

NCT04678154Recruiting

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT

The proposed study is a multi-center, prospective randomized controlled trial comparing current standard of care treatment to the SEXTANT treatment protocol in patients with Type III open fractures of...

Baltimore, MDPHASE3600 participantsMajor Extremity Trauma Research Consortium

View Study Details

NCT05463289Recruiting

ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2

The purpose of this study is to determine if use of a nonmydriatic fundus camera using autonomous artificial intelligence software at the point of care increases the proportion of underserved youth wi...

Baltimore, MDNA500 participantsJohns Hopkins University

View Study Details

NCT06293469Recruiting

Accelerated Flap Coverage in Severe Lower Extremity Trauma

The goal of this randomized controlled trial is to determine if accelerated flap coverage compared to standard flap coverage timing leads to improved infection-related complications in patients with o...

Baltimore, MDNA356 participantsJohns Hopkins University

View Study Details

NCT06789913Recruiting

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation

This is a 3-part Phase 2 randomized study evaluating the safety and efficacy of the mutant-selective PI3Kα inhibitor, RLY-2608, in adults and children with PIK3CA Related Overgrowth Spectrum (PROS) an...

Baltimore, MDPHASE2277 participantsRelay Therapeutics, Inc.

View Study Details

NCT06777901Recruiting

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone

The goal of this clinical trial is to learn if the Auryon Atherectomy System with balloon angioplasty safe and effective in treating lower limb blockages. The main question it aims to answer is: Is tr...

Baltimore, MDPHASE4224 participantsAngiodynamics, Inc.

View Study Details

NCT04228978Recruiting

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

The PROVE Trial is a randomized clinical trial that will determine whether a weight loss intervention combined with walking exercise achieves greater improvement or less decline in six-minute walk dis...

Baltimore, MDNA212 participantsNorthwestern University

View Study Details

NCT05361941Recruiting

Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/near Infected Bone Cavities

This is a pivotal, prospective, multi-center, randomized, concurrent control, patient and assessor-blinded study with two arms: a treatment arm (where subjects will be treated with the EP Granules wit...

Baltimore, MDNA204 participantsElute, Inc.

View Study Details

NCT07293689Recruiting

PREcision MEDicine In Achalasia (PREMEDIA) - Cohort

The goal of this observational study is to learn about how the doctor decides how long to cut t the esophageal muscle during Per-Oral Endoscopic Myotomy (POEM) in patients with difficulty swallowing d...

Baltimore, MD200 participantsNorthwestern University

View Study Details

NCT06810180Recruiting

Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD

Attention deficit/hyperactivity disorder (ADHD) can present differently in individuals, with some individuals having difficulty with attentional control, hyperactivity, impulsivity, emotion dysregulat...

Baltimore, MDNA200 participantsHugo W. Moser Research Institute at Kennedy Krieger, Inc.

View Study Details

NCT07023614Recruiting

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

FORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and safety of ninerafaxstat compared to placebo on top of Standard...

Baltimore, MDPHASE2165 participantsImbria Pharmaceuticals, Inc.

View Study Details

NCT06364644Recruiting

Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure

This study aims to determine whether a 6-month multilevel intervention involving problem-solving training, exercise training and support from community health workers is more effective in improving ou...

Baltimore, MDNA156 participantsJohns Hopkins University

View Study Details

NCT03813407Recruiting

An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia

Sodium zirconium cyclosilicate has been shown to be effective and safe in adults for the treatment of hyperkalaemia, and therefore it is expected to be beneficial in children. This study will evaluate...

Baltimore, MDPHASE3140 participantsAstraZeneca

View Study Details

NCT07351123Recruiting

Assessment of Treatment Variability for Pelvic Ring Fragility Fractures

Fragility fractures of the pelvic ring are a common injury associated with poor patient outcomes and high healthcare costs. Management of these injuries is evolving with increasing frequency of operat...

Baltimore, MD120 participantsUniversity of Maryland, Baltimore

View Study Details

NCT06708299Recruiting

CardiolRx in Recurrent Pericarditis Following IL-1 Blocker Cessation

Multi-center, randomized, double-blind, placebo-controlled, phase-3 Trial. Patients with a history of recurrent pericarditis who are being treated with an IL-1 blocker for at least 12 months, schedule...

Baltimore, MDPHASE3110 participantsCardiol Therapeutics Inc.

View Study Details

NCT04374305Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with NF2-related schwannomatosis (NF2-SWN, formerly known as ne...

Baltimore, MDPHASE2109 participantsScott R. Plotkin, MD, PhD

View Study Details

NCT06921356Recruiting

Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes

People with high blood pressure and diabetes often have low levels of key nutrients as a result of not eating enough fresh fruits and vegetables. Research studies suggest that these nutrients can lowe...

Baltimore, MDNA80 participantsJohns Hopkins University

View Study Details

NCT06992440Recruiting

Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension

Randomized, triple-masked, parallel arm clinical trial of empagliflozin versus placebo in pulmonary arterial hypertension (PAH) participants on stable approved PAH-targeted medical therapy....

Baltimore, MDPHASE278 participantsGustavo A Heresi, MD, MS

View Study Details

NCT06066983Recruiting

DINO RCT - Treating Anxiety in Children With Autism

Anxiety is prevalent in young children, under 7 years of age, with autism. Yet, few studies have examined anxiety interventions for this age range, and only one anxiety treatment study has included yo...

Baltimore, MDNA70 participantsHugo W. Moser Research Institute at Kennedy Krieger, Inc.

View Study Details

NCT07015996Recruiting

Efficacy of Tezepelumab in Peanut Oral Immunotherapy

The proposed study is a proof-of-concept Phase 2, double-blind, randomized placebo-controlled clinical trial evaluating the safety and efficacy of tezepelumab and peanut Oral Immunotherapy (OIT) for t...

Baltimore, MDPHASE262 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT03887481Recruiting

Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA

AD afflicts over 5.5. million Americans and is one of the most expensive diseases worldwide. In AD the variant in which language functions are most affected are referred to as 'logopenic variant Prima...

Baltimore, MDNA60 participantsJohns Hopkins University

View Study Details

NCT04786262Recruiting

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia....

Baltimore, MDPHASE357 participantsVertex Pharmaceuticals Incorporated

View Study Details

NCT04401982Recruiting

Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects

The goal of this clinical trial is to compare participants treated with latanoprost to those treated with Rocklatan (netarsudil/latanoprost) to determine whether the addition of netarsudil results in ...

Baltimore, MDPHASE450 participantsUniversity of Maryland, Baltimore

View Study Details

NCT04131413Recruiting

HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia

The primary goal of this phase I open label study is to determine the safety and tolerability of pNGVL4aCRTE6E7L2 DNA vaccine, as administered by intramuscular (IM) injection with TriGrid™ electropora...

Baltimore, MDPHASE148 participantsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

View Study Details

NCT04113382Recruiting

Study Assessing CLENPIQ As Bowel Preparation for Pediatric Colonoscopy

Bowel preparation for pediatric colonoscopy....

Baltimore, MDPHASE139 participantsFerring Pharmaceuticals

View Study Details

NCT05705024Recruiting

Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells

The proposed Conventional Cohort Expansion Study involves the use of Mesenchymal Stromal Cells (MSCs) are derived from the bone marrow. We previously studied the safety of subconjunctival injection of...

Baltimore, MDPHASE238 participantsUniversity of Illinois at Chicago

View Study Details

NCT04781972Recruiting

Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD

The investigators' goal is to develop neuroimaging biomarkers to predict response to treatment with methylphenidate, which then can be used in the development of novel pharmacological treatments for a...

Baltimore, MDPHASE430 participantsJohns Hopkins University

View Study Details

NCT07226453Recruiting

Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

This is a multi-site study of the pharmacodynamic effects and efficacy of metformin in children and young adults with recurrent or progressive Posterior Fossa Group A (PFA) ependymoma....

Baltimore, MDPHASE230 participantsUniversity of California, San Francisco

View Study Details

NCT06541847Recruiting

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

The trial will be an open label, single arm, phase 2 study in 20 participants. The study will assess the tolerability and efficacy of HLX-1502 in participants with NF1 16 years of age or older with pr...

Baltimore, MDPHASE225 participantsHealx Limited

View Study Details

NCT05656235Recruiting

Renal Retention in High Grade Upper Tract Urothelial Cancer

This trial will evaluate the use of combination pembrolizumab and enfortumab vedotin for patients with high grade non-metastatic (cN0/NxMx, no measurable regional lymph nodes, no metastases) upper tra...

Baltimore, MDPHASE220 participantsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

View Study Details

NCT07222085Recruiting

Long-Term Stability of the Glide Control Strategy

This research is intended to test whether the prescription of the Glide prosthesis control system reduces the burden of use for both patients and their clinical care team as compared to use of Pattern...

Baltimore, MDNA12 participantsInfinite Biomedical Technologies

View Study Details

NCT06367608Recruiting

MRgFUS Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD)

The purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating task specific focal hand dystonias (TSFD). TSFD is a type of dystonia that af...

Baltimore, MDNA10 participantsUniversity of Maryland, Baltimore

View Study Details

About Pulmonary Embolism Clinical Trials in Baltimore

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 37 pulmonary embolism clinical trials recruiting participants in Baltimore, MD. These studies are seeking a combined 12,292 participants. Research is being sponsored by George Washington University, Washington University School of Medicine, University of Milano Bicocca and 22 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Baltimore — FAQ

Are there pulmonary embolism clinical trials in Baltimore?

Yes, there are 37 pulmonary embolism clinical trials currently recruiting in Baltimore, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Baltimore?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.

Are clinical trials in Baltimore free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 37 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated September 19, 2026 from ClinicalTrials.gov